STOCK TITAN

AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AbbVie (NYSE: ABBV) to participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. Key executives to present at the event, with a live audio webcast accessible through AbbVie's Investor Relations website.
Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Jan. 2, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D. senior vice president, development and regulatory affairs and chief medical officer, will present at 10:15 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019269.html

SOURCE AbbVie

FAQ

When will AbbVie participate in the 42nd Annual J.P. Morgan Healthcare Conference?

AbbVie will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024.

Who are the key executives presenting at the conference from AbbVie?

Robert A. Michael, Scott T. Reents, Jeffrey R. Stewart, and Roopal Thakkar, M.D. will be presenting at the conference.

Where can I access the live audio webcast of AbbVie's presentation?

The live audio webcast of AbbVie's presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com.

Will an archived edition of the session be available after the presentation?

Yes, an archived edition of the session will be available later on the same day.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

290.01B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.